SNY | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 0%

Performance

5 Days

0.57%

1 Month

2.19%

3 Months

2.19%

6 Months

2.19%

1 Year

2.19%

2 Year

2.19%

Key data

Stock price

$47.99

P/E Ratio

N/A

DAY RANGE

$47.78 - $48.34

EPS

N/A

52 WEEK RANGE

$46.06 - $48.59

52 WEEK CHANGE

$2.19

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$2,591,573

AVERAGE 30 VOLUME

$2,591,573

Company detail

CEO: Paul Hudson
Region: US
Website: sanofi.com
Employees: 91,600
IPO year: 2002

Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation.

SNY - Sanofi